RADx-Rad Discoveries & Data: Consortium Coordination Center Program Organization
RADx-Rad 发现
基本信息
- 批准号:10321007
- 负责人:
- 金额:$ 584.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-12-21 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:AgreementAntibodiesAreaAwardBackBenchmarkingBiological AssayCOVID-19COVID-19 diagnosticCOVID-19 pandemicCOVID-19 testingCalibrationCaliforniaClinical PathologyClinical ResearchCloud ComputingCloud ServiceCollaborationsCommunicable DiseasesCommunicationCommunitiesComputer softwareConsultationsDataData CollectionData Coordinating CenterData DiscoveryData ScienceData ScientistData SourcesDevelopmentDiagnosticDiagnostic testsEnsureEvaluationFAIR principlesFDA approvedFundingGoalsGoldHealth Insurance Portability and Accountability ActHealth SciencesInformaticsInternetKnowledgeLaboratoriesLogisticsMetadataMethodsOnline SystemsPersonsPositioning AttributePreparationPrivacyProceduresProcessProtocols documentationQuality ControlRADxRADx RadicalReportingResearch PersonnelResourcesRiskRoleSARS-CoV-2 infectionSamplingScienceSecureSecuritySemanticsSignal TransductionSpecialistSpecimenStandardizationStructureTechnologyTerminologyTestingTexasTimeUnited States National Institutes of HealthUniversitiesUpdateValidationViralViral Load resultVirusWorkbasedashboarddata accessdata centersdata exchangedata managementdata modelingdata reusedata sharingdata standardsdesigndiagnostic technologiesdistributed dataexpectationexperiencehelp-seeking behaviorindexinginnovationmeetingsmembernew technologynewsnovel diagnosticsprogramsquality assurancerepositorysearch enginesyntaxtesting servicestooltransmission processuser centered designuser-friendlyvirology
项目摘要
ABSTRACT
Preparing SARS-CoV-2 testing data for reuse requires making the data syntactically and semantically equivalent.
Standardization of terminologies and a common data model accomplish the former, while the latter is
accomplished through understanding the data and making it comparable across RADx-rad awardees by
benchmarking against known gold standards. The standardization of samples is as important as standardizing
the data, particularly in the highly innovative RADx-rad program, where new technologies will be developed or
optimized for deployment in various settings. Highly motivated RADx-rad awardees will receive advice on how
their diagnostics compare to FDA-approved ones, with each other, how their diagnostic performs in independent
testing, as well as how to ensure the tests are usable in real world settings. In collaboration with University of
Texas Health Science Center at Houston, University of California San Diego researchers in informatics/data
science and infectious diseases with ample experience in leading large consortia have designed a unique RADx-
rad Consortium Data and Coordination Center (radCDCC). This center is based on three pillars: (1) effective
administration and coordination among awardees, NIH, and other programs;; (2) innovative approaches and tools
to collect and standardize data and metadata to promote findability, accessibility, interoperability and reuse
(FAIR) for data sharing;; and (3) principled preparation of standardized samples with known quantities of viral
loads, and standardized procedures for testing new diagnostics to allow comparison across tests and calibration
of new technologies. Backed by sophisticated HIPAA-compliant cloud services, user friendly web-tools, and
extensive support from UCSD’s facilities for computation and for clinical research, the radCDCC will interface
with other RADx programs and other COVID-19 focused programs at NIH to ensure alignment of awardees, NIH
and the public in the pursuit of effective, affordable, and deployable new technologies for testing.
文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eliah S Aronoff-Spencer其他文献
Eliah S Aronoff-Spencer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eliah S Aronoff-Spencer', 18)}}的其他基金
RADx-Rad Discoveries & Data: Consortium Coordination Center Program Organization
RADx-Rad 发现
- 批准号:
10745886 - 财政年份:2023
- 资助金额:
$ 584.89万 - 项目类别:
RADx-Rad Discoveries & Data: Consortium Coordination Center Program Organization
RADx-Rad 发现
- 批准号:
10274180 - 财政年份:2020
- 资助金额:
$ 584.89万 - 项目类别:
RADx-Rad Discoveries & Data: Consortium Coordination Center Program Organization
RADx-Rad 发现
- 批准号:
10854683 - 财政年份:2020
- 资助金额:
$ 584.89万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 584.89万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 584.89万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 584.89万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 584.89万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 584.89万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 584.89万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 584.89万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 584.89万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 584.89万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 584.89万 - 项目类别:














{{item.name}}会员




